Human serum paraoxonase (PON1) concentration predicts cardiovascular disease in diabetic patients

被引：0
|
作者：
Inoue, M. [1 ]
Ikeda, Y. [1 ]
Suehiro, T. [1 ]
Takata, H. [1 ]
Inada, S. [1 ]
Ogami, N. [1 ]
Osaki, F. [1 ]
Arii, K. [1 ]
Hashimoto, K. [1 ]
机构：
[1] Kochi Univ, Sch Med, Nankoku, Kochi, Japan
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2006年 / 7卷 / 03期
关键词：
D O I：
10.1016/S1567-5688(06)81393-0
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
WeP1137
引用
收藏
页码：354 / 354
页数：1
相关论文
共 50 条
  • [21] PARAOXONASE 1 (PON1) GENE POLYMORPHISMS, PON1 EXPRESSION IN PBMCS, AND SERUM PON1 ACTIVITY CONCERNING DYSLIPIDEMIA AND RELATED COMORBIDITIES IN HEMODIALYSIS (HD) PATIENTS
    Grzegorzewska, Alicja Ewa
    Lwanczyk-Skalska, Ewa
    Adamska, Paulina
    Niepolski, Leszek
    Mostowska, Adrianna
    Warchol, Wojciech
    Jagodzinski, Pawel
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 1598 - 1598
  • [22] Paraoxonase-1 (PON1) activity in patients with coronary artery diseases and in diabetic patients
    Amine, Khadija
    Atouk, Abdelouahed
    Moussamih, Samya
    Saile, Rachid
    Mikou, Afaf
    Kettani, Anass
    ANNALES DE BIOLOGIE CLINIQUE, 2011, 69 (06) : 671 - 677
  • [23] The effects of paraoxonase (PON1) polymorphisms in the coding region and environmental factors on serum PON1 activity
    Jintana, Sirivarasai
    Sming, Kaojarern
    Krongtong, Yoovathawom
    Thanyachai, Sura
    ANNALS OF NUTRITION AND METABOLISM, 2007, 51 : 112 - 112
  • [24] The relationship of PON1 QR 192 and LM 55 polymorphisms with serum paraoxonase activities of Turkish diabetic patients
    Altuner, Durdu
    Ates, Ilker
    Suzen, Sinan H.
    Koc, Gonul Varan
    Aral, Yalcin
    Karakaya, Asuman
    TOXICOLOGY AND INDUSTRIAL HEALTH, 2011, 27 (10) : 873 - 878
  • [25] Homocysteine levels, paraoxonase 1 (PON1) activity, and cardiovascular risk
    Vos, Eddie
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (02): : 168 - 169
  • [26] Expression of human paraoxonase (PON1) during development
    Cole, TB
    Jampsa, RL
    Walter, BJ
    Arndt, TL
    Richter, RJ
    Shih, DM
    Tward, A
    Lusis, AJ
    Jack, RM
    Costa, LG
    Furlong, CE
    PHARMACOGENETICS, 2003, 13 (06): : 357 - 364
  • [27] Paraoxonase (PON1) enzyme activity predicts vascular disease independently of PON1 promoter region or coding polymorphisms and of smoking and antihyperlipidemic use
    Jarvik, GP
    Heagerty, P
    Hatsukami, T
    Furlong, CE
    CIRCULATION, 2002, 105 (14) : E91 - E91
  • [28] Effects of Intronic and Exonic Polymorphisms of Paraoxonase 1 (PON1) Gene on Serum PON1 Activity in a Korean Population
    Eom, Sang-Yong
    Kim, Yun-Sik
    Lee, Chung-Jong
    Lee, Chul-Ho
    Kim, Yong-Dae
    Kim, Heon
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2011, 26 (06) : 720 - 725
  • [29] Serum paraoxonase 1 (PON1) activity in acute pancreatitis of dogs
    Tvarijonaviciute, A.
    Garcia-Martinez, J. D.
    Caldin, M.
    Martinez-Subiela, S.
    Tecles, F.
    Pastor, J.
    Ceron, J. J.
    JOURNAL OF SMALL ANIMAL PRACTICE, 2015, 56 (01) : 67 - 71
  • [30] Investigation of Inhibition of Busulfan (Chemotherapeutic Drug) on Human Serum Paraoxonase-1 (PON1)
    Soyut, Hakan
    INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2021, 17 (08) : 572 - 576
12345